

Accelerating miRNA research – new approaches for low- and high-throughput phenol-free miRNA isolation from liquid biopsy samples Print Bookmark Share more.. miRNA profiling holds high expectations as a non-invasive way to discover molecular biomarkers for human diseases. While miRNAs are released into plasma where they can be easily collected and analyzed, the choice of extraction method affects miRNA yield, quality and compatibility with downstream applications (qPCR, NGS). The presentation will cover common considerations and challenges when isolating miRNA from liquid biopsy samples – and new solutions for phenol-free, high-throughput isolation of cell-free miRNA. miRNA profiling holds high expectations as a non-invasive way to discover molecular biomarkers for human diseases. While miRNAs are released into plasma where they can be easily collected and analyzed, the choice of extraction method affects miRNA yield, quality and compatibility with downstream applications (qPCR, NGS). The presentation will cover common considerations and challenges when isolating miRNA from liquid biopsy samples – and new solutions for phenol-free, high-throughput isolation of cell-free miRNA. Hide details Constanze Kindler, Ph.D. Dr. Constanze Kindler joined QIAGEN in Hilden, Germany in 1993, where she held various positions in Sales and Global Marketing. She received her Ph.D. in Molecular Biology from the University of Münster in 1993. Dr. Kindler is currently an Associate Director, Global Product Management, Sample Technologies with a focus on Liquid Biopsy applications.. Dr. Constanze Kindler joined QIAGEN in Hilden, Germany in 1993, where she held various positions in Sales and Global Marketing. She received her Ph.D. in Molecular Biology from the University of Münster in 1993. Dr. Kindler is currently an Associate Director, Global Product Management, Sample Technologies with a focus on Liquid Biopsy applications.. Hide details Contact QIAGEN Global contacts Technical Service Customer Care QIAGEN Apps Apps for your mobile devices! See apps

Accelerating miRNA research – new approaches for low- and high-throughput phenol-free miRNA isolation from liquid biopsy samples

miRNA profiling holds high expectations as a non-invasive way to discover molecular biomarkers for human diseases. While miRNAs are released into plasma where they can be easily collected and analyzed, the choice of extraction method affects miRNA yield, quality and compatibility with downstream applications (qPCR, NGS). The presentation will cover common considerations and challenges when isolating miRNA from liquid biopsy samples – and new solutions for phenol-free, high-throughput isolation of cell-free miRNA.

Constanze Kindler, Ph.D.

Dr. Constanze Kindler joined QIAGEN in Hilden, Germany in 1993, where she held various positions in Sales and Global Marketing. She received her Ph.D. in Molecular Biology from the University of Münster in 1993. Dr. Kindler is currently an Associate Director, Global Product Management, Sample Technologies with a focus on Liquid Biopsy applications..

Contact QIAGEN

Global contacts

Technical Service

Customer Care

QIAGEN Apps

Apps for your mobile devices!

See apps